About Our Program
The Interdisciplinary Faculty of Toxicology (IFT) is a graduate studies program that is composed of faculty from multiple colleges, departments, and laboratories at the university. Since 1989, over 50 MS students, nearly 200 PhD students, and two DVM/PhD students have earned a Texas A&M Toxicology degree. In addition, well over 100 post-doctoral students have trained in our program.
Areas Of Research
- Mechanistic Toxicology
- Data Science & Modeling
- Epidemiology
- Community Engagement
- Environmental Chemistry
- Biomedical Engineering
- Public Policy
Trainees In Action
Training the future generation of toxicologists in novel scientific discoveries should go hand-in-hand with ensuring that trainees develop a broad set of complementary competencies that span multiple disciplines from basic biology to exposure science, biostatistics, and epidemiology. Trainees must also understand how these data and knowledge are translated into decisions and policy.
Program News
- Toxic water in South Texas colonias costs residents precious health and money June 16, 2023
- Texas A&M Superfund Research Center Developing Practical Solutions To Disaster Effects, Chemical Contaminants June 14, 2026
- Can coffee prevent cancer? Research suggests java may offer benefits also found in vegetable-rich diets April 26, 2023
- The role of a common agricultural chemical in chronic kidney disease March 22, 2023
- TOXICOLOGY TRAINEES RECIEVE AWARDS AT THE 2023 SOCIETY OF TOXICOLOGY ANNUAL MEETING March 27, 2023
- Diet may contribute to development of Alzheimer’s disease, according to new NIH-funded study March 9, 2023
- TEXAS A&M UNIVERSITY SPOTLIGHTS IMMUNOLOGY RESEARCH AT INAUGURAL SYMPOSIUM February 28, 2023
- New breakthrough in understanding fentanyl abuse February 15, 2023
- Eight Faculty Earn Texas A&M’s Highest Honor February 13, 2023
- VMBS, VERO MAKE IMPACT AT ANIMAL DISEASE RESEARCH CONFERENCE February 9, 2023
- Texas A&M Postdoc Receives NIH Grant for Toxicology Research February 7, 2023
- Texas A&M Researchers To Further Develop Unique Cancer Drug With $2.3 Million NIH Grant February 1, 2023